about
Tacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantationHistone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in miceTacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantationOral complications in hematopoietic stem cell recipients: the role of inflammationCeacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationGenetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donorsHigh-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.Pathogenesis and management of graft-versus-host disease.Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin.Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in miceXenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host diseaseEffects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation.An epidermotypic model of interface dermatitis reveals individual functions of fas ligand and gamma interferon in hypergranulosis, cytoid body formation, and gene expression.Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissueAcute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammationMyxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cellsDonor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantationRecipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation.Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.Pathophysiology of acute graft-versus-host disease: recent advances.Overview of T-cell depletion in haploidentical stem cell transplantation.Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.Genetics of graft-versus-host disease: the major histocompatibility complex.Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation.Oral graft-versus-host disease.A biomarker panel for acute graft-versus-host diseaseHistone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.Advances in the treatment of acute graft-versus-host disease.Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease.Early onset of syndrome of inappropriate antidiuretic hormone secretion (SIADH) after allogeneic haematopoietic stem cell transplantation: case report and review of the literature.Treatment of graft-versus-host disease with monoclonal antibodies and related fusion proteins.
P2860
Q24235827-4F88EE77-0D62-44A1-B32A-B2D610F7E3D3Q24288997-7B1C8516-4394-4423-B089-2074E5028B12Q26472072-F5EA35F0-09B1-4F69-90A0-3C24252CF942Q27027650-E062B63A-A7B7-4BE8-AFFB-353874BFCD56Q27334243-7A0F4B75-68C8-4647-9173-DF244F416D11Q33747297-3D26CA0A-B7B2-489C-A073-AC037DCC204AQ33995557-0A346FC3-C5F0-438D-8D18-1136F8CC016CQ34077479-DCFD938B-7EB9-40AB-B02F-8FBE63F15D8AQ34161256-FA0B4C71-F183-45D7-8E2D-83CFD94C2D11Q34276582-E6591FDC-7234-43BF-97E9-0438E064DD6BQ34399707-BD587898-0CBE-4A8E-990F-8250F057B5B8Q34443622-1EC4645D-1EDF-4D2A-867A-866AB14C8D63Q34491107-BDE16452-B18E-43F3-8EA2-8EB1DAD2FFC1Q34673038-E3E3C8DF-9E2F-4A35-9A37-B9BE25CD3F73Q34772275-B5169194-17DD-4AA9-8366-BC9A0A2E59D5Q34843615-E1514656-5780-4DF2-AF97-2ED1FECD60DAQ34924388-B18EC772-DEFF-40F9-AEAA-CEB55072D183Q35534266-1E859E21-CFE0-4FCA-A794-10AFFCA985B1Q35602698-EF3D5308-1164-461D-9557-572EFED8ED6CQ35724025-AA2E48AA-9ECF-4BAA-8701-9B4315401CF0Q35804518-D50CFD93-8F59-41CF-96E9-CF50155A3754Q35859478-98F8B8A1-560C-421E-B7B6-792AC70170F5Q35928084-92860AFF-8C18-452C-8736-7CF18A9119D4Q36015721-EC895823-2394-447D-897B-A70CFD820728Q36156559-A7ED72C1-B43D-4D30-A847-371A71399FFFQ36159937-2F9FBE31-0534-4820-BFD1-342F49371941Q36615576-C5012793-A4A5-4D19-8A49-DB52CAF27470Q36672687-CC500E80-3888-4753-9910-C3C9907F168DQ36766250-728FF641-D3DB-465E-BA99-28304A0B73CEQ36808062-CC08BC48-41D0-4E84-8ED9-28B870B59D2FQ36835147-453F933A-0196-47DD-BDAA-2E8C64E3A37CQ36932886-685B8D97-0160-45C9-9C93-B1F4A62ABF6EQ37041904-2934184C-C97B-4ABA-BBF8-4E50887F6BE7Q37095317-1B650926-7A17-4121-AF0F-A14C9CA0C48AQ37191057-97AFC796-836E-448C-A924-CD45AEE1ADE0Q37215167-2D188E1B-CE11-4C0D-A8BF-B7E2DC0F5FEDQ37246752-A9A6DCDB-71BA-40F2-B97E-08762033D262Q37718993-77946C21-5881-41CF-88CD-9343C93D8323Q37761940-6E244814-AF74-4F00-B390-42A4A369EB19Q37810286-231CA5D7-B46D-42E5-97E5-B0CEBAB4A402
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Immunobiology of acute graft-versus-host disease.
@ast
Immunobiology of acute graft-versus-host disease.
@en
type
label
Immunobiology of acute graft-versus-host disease.
@ast
Immunobiology of acute graft-versus-host disease.
@en
prefLabel
Immunobiology of acute graft-versus-host disease.
@ast
Immunobiology of acute graft-versus-host disease.
@en
P1433
P1476
Immunobiology of acute graft-versus-host disease.
@en
P2093
James L M Ferrara
Pavan Reddy
P304
P356
10.1016/S0268-960X(03)00009-2
P577
2003-12-01T00:00:00Z